Quantitative thin-layer chromatographic measurement of n-trifluoroacetyladriamycin-14-valerate (AD 32) and trifluoroacetyladriamycin (AD 41) in blood and tissues. 1979

B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona

A thin-layer chromatographic method has been developed for the detection and measurement of N-trifluoroacetyladriamycin-14-valerate (AD 32) and its major metabolite trifluoroacetyladriamycin (AD 41). The procedure gives satisfactory linearity over a large range of concentrations. The coefficient of variability is about 10% over the entire range of usable concentrations, giving good reproducibility; sensitivity is 25 ng for both AD 32 and AD 41. Analysis is specific for AD 32 and AD 41 since adriamycin or more polar metabolites can be differentiated. Recovery is high (85-90%) and the method is simple and economical to use. Pharmacokinetics of AD 32 and AD 41 are reported in blood and some tissues of mice bearing Lewis Lung carcinoma.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
April 1985, Teratology,
B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
May 1979, Cancer treatment reports,
B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
January 1991, Cancer chemotherapy and pharmacology,
B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
January 1987, Cancer chemotherapy and pharmacology,
B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
February 1992, Biochemical pharmacology,
B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
January 1980, Cancer chemotherapy and pharmacology,
B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
January 1978, Cancer treatment reports,
B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
January 1978, Cancer treatment reports,
B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
March 1997, Urology,
B Barbieri, and R Abbruzzi, and A Benigni, and M Rizzardini, and M G Donelli, and S Garattini, and M Salmona
June 1976, Cancer research,
Copied contents to your clipboard!